Download App

Log in to access Online Inquiry
Company Overview More
RedHill Biopharma Ltd., a specialty biopharmaceutical company, primarily focuses on gastrointestinal and infectious diseases. The company promotes gastrointestinal drugs, including Movantik for opioid-induced constipation in adults with chronic non-cancer pain; Talicia for the treatment of Helicobacter pylori infection in adults; and Aemcolo for the treatment of travelers’ diarrhea in adults. Its clinical late-stage investigational development programs include RHB-204, which is in Phase 3 study for pulmonary nontuberculous mycobacteria infections; opaganib (Yeliva), an SK2 selective inhibitor, which has completed Phase 2 study to treat patients with SARS-CoV-2 severe COVID-19 pneumonia, in Phase 2 study to treat advanced unresectable cholangiocarcinoma, and in investigator-sponsored Phase 2 study to treat prostate cancer; RHB-107, which is in Phase 2/3 study to treat outpatients infected with COVID-19 disease, and preclinical evaluation study to treat advanced unresectable cholangiocarcinoma, as well as has completed Phase 2 study to treat gastrointestinal and other solid tumors; RHB-104, which is in Phase 3 studies for Crohn's disease; RHB-102 (Bekinda) that is in Phase 3 studies for acute gastroenteritis and gastritis, and has completed Phase 2 studies for irritable bowel syndrome with diarrhea; and RHB-106, an encapsulated formulation for bowel preparation, which is preparing for Phase 2/3 study. RedHill Biopharma Ltd. was incorporated in 2009 and is headquartered in Tel Aviv, Israel.
CEO: Ben-Asher, Dror
Market: NASDAQ
Hot List
TradeSearchNews
SymbolLatest price%Chg

Loading...

Moomoo > Quotes > RDHL Redhill Biopharma > Detailed Quotes

RDHL Redhill Biopharma

1.070+0.110+11.46%
Close 05/27 20:00 ET
1.07000.00%
Post Mkt Price 05/27 19:35 ET
High
1.070
Open
1.060
Turnover
240.16K
Low
0.988
Pre Close
0.960
Volume
231.13K
Market Cap
56.99M
P/E(TTM)
Loss
52wk High
11.180
Shares
53.26M
P/E(Static)
Loss
52wk Low
0.900
Float Cap
42.69M
Bid/Ask %
-80.00%
Historical High
22.220
Shs Float
39.89M
Volume Ratio
0.69
Historical Low
0.900
Dividend TTM
--
Div Yield TTM
25
P/B
6.41
Dividend LFY
--
Div Yield LFY
2336.45%
Turnover Ratio
0.58%
Amplitude
8.59%
Avg Price
1.039
Lot Size
1
Float Cap
42.69M
Bid/Ask %
-80.00%
Historical High
22.220
Shs Float
39.89M
Volume Ratio
0.69
Historical Low
0.900
Dividend TTM
--
P/B
6.41
Dividend LFY
--
Turnover Ratio
0.58%
Amplitude
8.59%
Avg Price
1.039
Lot Size
1
Price Forecast

No Data

News

Comment